Yeming Wang to Female
This is a "connection" page, showing publications Yeming Wang has written about Female.
Connection Strength
0.103
-
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza. EBioMedicine. 2020 Dec; 62:103125.
Score: 0.012
-
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24; 21(1):422.
Score: 0.012
-
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 05 16; 395(10236):1569-1578.
Score: 0.012
-
Regional characteristics of cortical bone quality in the proximal humerus of postmenopausal women: a preliminary study. J Shoulder Elbow Surg. 2019 Apr; 28(4):685-691.
Score: 0.011
-
Regional variations of cortical bone in the humeral head region: A preliminary study. Bone. 2018 05; 110:194-198.
Score: 0.010
-
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021 Dec; 10(1):664-676.
Score: 0.003
-
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021 08 28; 398(10302):747-758.
Score: 0.003
-
The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients. BMC Infect Dis. 2021 Apr 20; 21(1):371.
Score: 0.003
-
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 01 16; 397(10270):220-232.
Score: 0.003
-
Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe COVID-19. Chest. 2021 04; 159(4):1382-1386.
Score: 0.003
-
High anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):2707-2714.
Score: 0.003
-
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Clin Microbiol Infect. 2021 Jan; 27(1):112-117.
Score: 0.003
-
Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020 09; 56(3).
Score: 0.003
-
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment. Eur Respir Rev. 2020 Sep 30; 29(157).
Score: 0.003
-
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front Med. 2020 Oct; 14(5):601-612.
Score: 0.003
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 05 07; 382(19):1787-1799.
Score: 0.003
-
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 03 28; 395(10229):1054-1062.
Score: 0.003
-
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 02 15; 395(10223):497-506.
Score: 0.003
-
Comparison of the Cepheid Xpert Xpress Flu/RSV assay and commercial real-time PCR for the detection of influenza A and influenza B in a prospective cohort from China. Int J Infect Dis. 2019 Mar; 80:92-97.
Score: 0.003
-
Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection. J Infect Dis. 2018 07 13; 218(4):586-594.
Score: 0.003
-
Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration. BMC Infect Dis. 2018 01 08; 18(1):23.
Score: 0.002